Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
Olson, Daniel J, Eroglu, Zeynep, Brockstein, Bruce, Poklepovic, Andrew S, Bajaj, Madhuri, Babu, Sunil, Hallmeyer, Sigrun, Velasco, Mario, Lutzky, Jose, Higgs, Emily, Bao, Riyue, Carll, Timothy C, Labadie, Brian, Krausz, Thomas, Zha, Yuanyuan, Karrison, Theodore, Sondak, Vernon K, Gajewski, Thomas F, Khushalani, Nikhil I, Luke, Jason J
Published in Journal of clinical oncology (20.08.2021)
Published in Journal of clinical oncology (20.08.2021)
Get full text
Journal Article
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
Sarnaik, Amod A, Hamid, Omid, Khushalani, Nikhil I, Lewis, Karl D, Medina, Theresa, Kluger, Harriet M, Thomas, Sajeve S, Domingo-Musibay, Evidio, Pavlick, Anna C, Whitman, Eric D, Martin-Algarra, Salvador, Corrie, Pippa, Curti, Brendan D, Oláh, Judit, Lutzky, Jose, Weber, Jeffrey S, Larkin, James M G, Shi, Wen, Takamura, Toshimi, Jagasia, Madan, Qin, Harry, Wu, Xiao, Chartier, Cecile, Graf Finckenstein, Friedrich, Fardis, Maria, Kirkwood, John M, Chesney, Jason A
Published in Journal of clinical oncology (20.08.2021)
Published in Journal of clinical oncology (20.08.2021)
Get full text
Journal Article
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
Ribas, Antoni, Algazi, Alain, Ascierto, Paolo A., Butler, Marcus O., Chandra, Sunandana, Gordon, Michael, Hernandez-Aya, Leonel, Lawrence, Donald, Lutzky, Jose, Miller, Wilson H., Campbell, Katie M., Delafont, Bruno, Marshall, Shannon, Mueller, Nancy, Robert, Caroline
Published in Nature communications (07.12.2020)
Published in Nature communications (07.12.2020)
Get full text
Journal Article
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
Wolchok, Jedd D, Dr, Neyns, Bart, MD, Linette, Gerald, MD, Negrier, Sylvie, Prof, Lutzky, Jose, MD, Thomas, Luc, Prof, Waterfield, William, MD, Schadendorf, Dirk, Prof, Smylie, Michael, Prof, Guthrie, Troy, MD, Grob, Jean-Jacques, Prof, Chesney, Jason, MD, Chin, Kevin, MD, Chen, Kun, PhD, Hoos, Axel, MD, O'Day, Steven J, MD, Lebbé, Celeste, Prof
Published in The lancet oncology (01.02.2010)
Published in The lancet oncology (01.02.2010)
Get full text
Journal Article
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition
Carvajal, Richard D, Lawrence, Donald P, Weber, Jeffrey S, Gajewski, Thomas F, Gonzalez, Rene, Lutzky, Jose, O'Day, Steven J, Hamid, Omid, Wolchok, Jedd D, Chapman, Paul B, Sullivan, Ryan J, Teitcher, Jerrold B, Ramaiya, Nikhil, Giobbie-Hurder, Anita, Antonescu, Cristina R, Heinrich, Michael C, Bastian, Boris C, Corless, Christopher L, Fletcher, Jonathan A, Hodi, F Stephen
Published in Clinical cancer research (15.05.2015)
Published in Clinical cancer research (15.05.2015)
Get full text
Journal Article
Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group
TESTORI, Alessandro, RICHARDS, Jon, YUH, Lianng, GUPTA, Renu, SRIVASTAVA, Pramod K, WHITMAN, Eric, MANN, G. Bruce, LUTZKY, Jose, CAMACHO, Luis, PARMIANI, Giorgio, TOSTI, Giulio, KIRKWOOD, John M, HOOS, Axel
Published in Journal of clinical oncology (20.02.2008)
Published in Journal of clinical oncology (20.02.2008)
Get full text
Journal Article
Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)
King, Jeanelle, de la Cruz, Javier, Lutzky, Jose
Published in Journal for immunotherapy of cancer (21.03.2017)
Published in Journal for immunotherapy of cancer (21.03.2017)
Get full text
Journal Article
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
Gibney, Geoffrey T, Hamid, Omid, Lutzky, Jose, Olszanski, Anthony J, Mitchell, Tara C, Gajewski, Thomas F, Chmielowski, Bartosz, Hanks, Brent A, Zhao, Yufan, Newton, Robert C, Maleski, Janet, Leopold, Lance, Weber, Jeffrey S
Published in Journal for immunotherapy of cancer (20.03.2019)
Published in Journal for immunotherapy of cancer (20.03.2019)
Get full text
Journal Article
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors
Sanborn, Rachel E, Pishvaian, Michael J, Callahan, Margaret K, Weise, Amy, Sikic, Branimir I, Rahma, Osama, Cho, Daniel C, Rizvi, Naiyer A, Sznol, Mario, Lutzky, Jose, Bauman, Julie E, Bitting, Rhonda L, Starodub, Alexander, Jimeno, Antonio, Reardon, David A, Kaley, Thomas, Iwamoto, Fabio, Baehring, Joachim M, Subramaniam, Deepa S, Aragon-Ching, Jeanny B, Hawthorne, Thomas R, Rawls, Tracey, Yellin, Michael, Keler, Tibor
Published in Journal for immunotherapy of cancer (01.08.2022)
Published in Journal for immunotherapy of cancer (01.08.2022)
Get full text
Journal Article
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
Ribas, Antoni, Algazi, Alain, Ascierto, Paolo A., Butler, Marcus O., Chandra, Sunandana, Gordon, Michael, Hernandez-Aya, Leonel, Lawrence, Donald, Lutzky, Jose, Miller, Wilson H., Campbell, Katie M., Delafont, Bruno, Marshall, Shannon, Mueller, Nancy, Robert, Caroline
Published in Nature communications (12.08.2021)
Published in Nature communications (12.08.2021)
Get full text
Journal Article
703 Single cell analysis of phase II study of nivolumab and relatlimab in metastatic uveal melanoma reveals tumor and immune response to dual PD-1 and LAG-3 inhibition
Dollar, James, Decatur, Christina, Cruz, Anthony, Durante, Michael, Huuhtanen, Jani, Mustjoki, Satu, Correa, Zelia, William Harbour, J, Lutzky, Jose
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
Khan, Shaheer, Lutzky, Jose, Shoushtari, Alexander N., Jeter, Joanne, Marr, Brian, Olencki, Thomas E., Cebulla, Colleen M., Abdel-Rahman, Mohamed, Harbour, J. William, Sender, Naomi, Nesson, Alexandra, Singh-Kandah, Shahnaz, Hernandez, Susana, King, Jeanelle, Katari, Manpreet S., Dimapanat, Lyssa, Izard, Stephanie, Ambrosini, Grazia, Surriga, Oliver, Rai, Alex J., Chiuzan, Codruta, Schwartz, Gary K., Carvajal, Richard D.
Published in Frontiers in oncology (29.08.2022)
Published in Frontiers in oncology (29.08.2022)
Get full text
Journal Article
Is primary breast melanoma a true pathological entity? The argument against it
Narvaez-Rojas, Alexis R., Linhares, Samantha, Sedighim, Shaina, Klingbeil, Kyle Daniel, Milikowski, Clara, Elgart, George, Jaimes, Natalia, Feun, Lynn, Lutzky, Jose, De la Cruz Ku, Gabriel, Avisar, Eli, Möller, Mecker G.
Published in Heliyon (30.09.2024)
Published in Heliyon (30.09.2024)
Get full text
Journal Article
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases
In, Gino K., Ribeiro, Jennifer R., Yin, Jun, Xiu, Joanne, Bustos, Matias A., Ito, Fumito, Chow, Frances, Zada, Gabriel, Hwang, Lindsay, Salama, April K. S., Park, Soo J., Moser, Justin C., Darabi, Sourat, Domingo-Musibay, Evidio, Ascierto, Maria L., Margolin, Kim, Lutzky, Jose, Gibney, Geoffrey T., Atkins, Michael B., Izar, Benjamin, Hoon, Dave S. B., VanderWalde, Ari M.
Published in NPJ precision oncology (14.11.2023)
Published in NPJ precision oncology (14.11.2023)
Get full text
Journal Article
1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial
Patel, Sapna P, Carvajal, Richard, Montazeri, Kamaneh, Reddy, Sunil, Lutzky, Jose, Khan, Shaheer A, Chmielowski, Bartosz, Bhatia, Shailender, Medina, Theresa, Haymaker, Cara, Sheth, Rahul, Kuban, Joshua D, Thornton, Lindsay, Wehrenberg-Klee, Eric, Novelli, Paula, Lucci, Anthony, Sarli, Vanessa, Meas, Salyna, Cox, Bryan, LaPorte, Jason, Guha, Prajna, Ghosh, Chandra C, Hulstine, Ann-Marie, Knight, Robert, Moody, Ashley, Geller, David, Katz, Steven, Orloff, Marlana, Davar, Diwakar
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
Clark, Joseph I, Singh, Jatinder, Ernstoff, Marc S, Lao, Christopher D, Flaherty, Lawrence E, Logan, Theodore F, Curti, Brendan, Agarwala, Sanjiv S, Taback, Bret, Cranmer, Lee, Lutzky, Jose, Luna, Theresa L, Aung, Sandra, Lawson, David H
Published in Journal for immunotherapy of cancer (27.07.2018)
Published in Journal for immunotherapy of cancer (27.07.2018)
Get full text
Journal Article
547 CERPASS: A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma
Haydon, Andrew, Alamgeer, Muhammad, Brungs, Daniel, Collichio, Frances, Khushalani, Nikhil, Colevas, Dimitrios, Rischin, Danny, Kudchadkar, Ragini, Chai-Ho, Wanxing, Daniels, Gregory, Lutzky, Jose, Lee, Jenny, Bowyer, Samantha, Migden, Michael, Silk, Ann, Lebbe, Celeste, Grob, Jean-jaques, Melero, Ignacio, Sheladia, Piyush, Bommareddy, Praveen, He, Shui, Andreu-Vieyra, Claudia, Fury, Matthew, Hill, Andrew
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Preliminary data from a multi-arm expansion study of MEDI4736, an anti-PD-L1 antibody
Segal, Neil Howard, Antonia, Scott Joseph, Brahmer, Julie R., Maio, Michele, Blake-Haskins, Andy, Li, Xia, Vasselli, Jim, Ibrahim, Ramy A., Lutzky, Jose, Khleif, Samir
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article